InVivo Therapeutics

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell NVIV and other ETFs, options, and stocks.

About NVIV

Invivo Therapeutics Holdings Corp. operates as a research and clinical-stage biotechnology company, which engages in developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries. Its clinical development program is the Neuro-Spinal Scaffold implant, which is an investigational bioresorbable polymer scaffold that is designed for implantation at the site of injury within a spinal cord. 

CEO
Richard Toselli
CEORichard Toselli
Employees
7
Employees7
Headquarters
Cambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded
2005
Founded2005
Employees
7
Employees7

NVIV Key Statistics

Market cap
4.21M
Market cap4.21M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
174.37K
Average volume174.37K
High today
$2.39
High today$2.39
Low today
$2.15
Low today$2.15
Open price
$2.22
Open price$2.22
Volume
33.31K
Volume33.31K
52 Week high
$16.00
52 Week high$16.00
52 Week low
$2.01
52 Week low$2.01

NVIV Earnings

-$2.25
-$1.50
-$0.75
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Estimated
per share
Estimated per share
Actual
Expected Mar 6, After Hours
ActualExpected Mar 6, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.